mortality in TTC patients (El-Battrawy, Lang, Ansari, Behnes, et al., 2017; Stiermaier, Santoro, et al., 2017) . AF is also commonly known as a poor outcome predictor among patients with ACS (Angeli et al., 2012; Lin et al., 2011; Maagh et al., 2011; Poci, Hartford, Karlsson, Edvardsson, & Caidahl, 2012; Podolecki et al., 2012; Stamboul et al., 2015; Viliani et al., 2012) . However, the association between AF and mortality in TTC patients is not well-established. In this study, we performed a meta-analysis to assess the association between the presence of AF and mortality in patients with TTC.
| ME THODS

| Search strategy
Two investigators (NL and VK) independently searched for published studies indexed in MEDLINE and EMBASE databases from inception to January 2018 using a search strategy (Figure 1 ) that included the terms "atrial fibrillation," "Takotsubo syndrome/cardiomyopathy," "Apical ballooning syndrome," "Broken heart syndrome" "stress cardiomyopathy" and "mortality." Only English language publications were included. A manual search for additional pertinent studies and review articles using references from retrieved articles was also completed.
| Study eligibility criteria
Two main criteria were assessed for inclusion of studies. First was the reporting of incidence of all-cause mortality in patients with TTC who presented with and without AF. Second was reporting of relative risk, hazard ratio, odds ratio, incidence ratio, or standardized incidence ratio with 95% confidence intervals (or sufficient raw data for the calculation). Patients with TTC who did not have AF were used as controls. Study eligibility was independently determined by two investigators (NL and VK). Differences were resolved by mutual consensus. The Newcastle-Ottawa quality assessment scale was used to evaluate each study in three domains: recruitment and F I G U R E 1 Search methodology and selection process Potentially relevant articles identified from search of MEDLINE (n = 21) and EMBASE database (n = 11) and screened for retrieval Title and abstract review of potentially relevant articles (n = 23) 1 excluded because it was a study design 1 excluded because it was a review article 1 excluded because it was an abstract 9 Exclusion of duplications 20 articles underwent full-length article review articles were excluded at this stage as they were -8 did not report mortality among patients in AF group -1 TC criteria by ICD10 -1 sample with the same database -3 no outcome of interest -2 no AF report 5 articles underwent meta-analysis selection of the participants, similarity and comparability between the groups, and ascertainment of the outcome of interest among cohort studies (Stang, 2010) .
| Definition
Takotsubo cardiomyopathy was defined according to Mayo Clinic Criteria (Madhavan & Prasad, 2010) described below.
• Transient hypokinesis, akinesis, or dyskinesis of the LV apical and/ or midventricular or basal segments extending beyond a single epicardial vessel distribution territory.
• Absence of significant obstructive coronary artery disease (CAD) explaining the extent of wall motion abnormalities and absence of acute plaque rupture on coronary angiography.
• New electrocardiographic abnormalities (either ST segment elevation and/or T-wave inversion) or modest elevation in cardiac troponin levels.
• Absence of pheochromocytoma and myocarditis.
| Data extraction
A standardized data collection form was used to obtain the following information from each study: title, name of first author, year of study, year of publication, country of origin, number of participants, demographic data of participants, method used to identify cases and controls, method used to diagnose the outcomes of interest (i.e., allcause mortality), average duration of follow-up, adjusted and unadjusted risk ratios and their corresponding 95% confidence interval, and list of confounders that were adjusted for in multivariate analysis. To ensure accuracy, all investigators independently performed this data extraction process. Any data discrepancy was resolved by referring back to the original articles.
| Statistical analysis
Meta-analysis of the combined data was performed using a randomeffects, generic inverse variance method of DerSimonian and Laird (DerSimonian & Laird, 1986) . The heterogeneity of effect size estimates across these studies was quantified using the I 2 statistic and Q statistic. For the Q statistic, substantial heterogeneity was defined as p < 0.10. The I 2 statistic ranges in value from 0% to 100% (I 2 < 25%, low heterogeneity; I 2 = 25%-50%, moderate heterogeneity; and I 2 > 50%, substantial heterogeneity) (Higgins, Thompson, Deeks, & Altman, 2003) . A sequential exclusion strategy, as described by Patsopoulos and colleagues, was used to examine whether overall estimates were influenced by the substantial heterogeneity observed. We sequentially and cumulatively excluded studies that accounted for the largest share of heterogeneity until I 2 was less than 50%. We then examined whether relative risk estimates were consistent. In accordance with Cochrane, publication bias was assessed using funnel plot. Funnel plot asymmetry was further confirmed with Egger's test if there were more than 10 available studies (Sterne & Egger, 2001 ). All analysis was performed using Review manager version 5.3 and STATA version 14.1.
| RE SULTS
| Description of included studies
Our search strategy yielded 32 potentially relevant articles (11 articles from EMBASE and 21 articles from MEDLINE). After exclusion of nine duplicated articles, 23 articles underwent title and abstract review. Three were excluded at this stage since one was an abstract, one was a description of study design and one was a review article, leaving 20 articles for full-length article review. Fifteen studies were excluded. Eight studies were excluded because they did not report numbers of patients with AF among the death group. One was excluded due to the same database (El-Battrawy, Lang, Ansari, Tulumen et al. ( 2017) . Three were excluded because there was no outcome of interest. One was excluded because the criteria of TCC were defined by ICD10 (Mahmoud, Al-Ani, Saad, Elgendy, & Elgendy, 2016) . Lastly, two were excluded due to no AF report in the studies.
Therefore, three retrospective and two prospective cohort studies with 243 AF and 2,078 without AF patients were included in this meta-analysis. The clinical characteristics are described in Table 1 .
| Quality assessment of included studies
The Newcastle-Ottawa scale (0 to 9) was used to evaluate included studies on three domains: selection, comparability, and outcomes.
Higher scores represent higher study quality. All five studies received a score of 7 to 9, which reflected high quality of included studies. Detailed evaluation of each study is presented in a Supporting
Information Table S1 .
| Meta-analysis result
A total of five studies (two prospective, three retrospective) with 2,321 participants were included in the meta-analysis. The prevalence of AF ranged from 6.4% to 25%. There was an association between AF and all-cause mortality in patients with TTC (OR 2.19; 95%CI 1.57-3.06, p < 0.001) with no heterogeneity (I 2 = 0%) ( Figure 2a ). Subgroup analysis of four studies with long-term mortality showed that the association remained significant and similar to overall analysis (OR 2.17; 95% CI 1.55-3.03, p < 0.001) with no heterogeneity (I 2 = 0%) as well ( Figure 2a) . Among five included studies, two studies reported multivariate adjusted OR (Ghadri, Cammann, & Napp, 2016; Stiermaier, Santoro, et al., 2017) . We performed subgroup analyses among multivariate adjusted (Ghadri et al, 2016; Stiermaier, Santoro, et al., 2017) and unadjusted studies (Dib et al., 2008; El-Battrawy, Lang, Ansari, Behnes, et al., 2017; Song et al., 2010) . We found that both multivariate adjusted and non-adjusted subgroup analyses showed substantial association between AF and risk of mortality in Takotsubo with similar OR (OR = 2.07 CI 1.34-3.20, p = 0.001, and OR = 2.43 CI 1.40-4.21, p = 0.002, respectively) and we found no significant different association between the two subgroups (p = 0.831, I 2 = 0%) (Figure 3 ). Low heterogeneity was found in multivariate adjusted (I 2 = 7%) and no heterogeneity (I 2 = 0%) was found in non-adjusted analyses.
Moreover, to evaluate the effect of adjusted studies on overall outcome, we performed meta-regression between multivariate adjusted and non-adjusted studies. We found that there was no significant difference among adjusted and unadjusted studies in overall random effect pooled analysis (p = 0.675).
Also, our exploratory analyses regarding cardiogenic shock and fatal arrhythmia were performed and demonstrated a statistically substantial association with AF depicted in Figure 2b . Funnel plot did not suggest publication bias (Figure 4 ). Egger's test was not performed due to a low number of the studies.
| D ISCUSS I ON
Our meta-analysis demonstrated that the presence of AF in patients with TTC was associated with increased risk of overall mortality.
The prevalence of AF ranged from 6.4% to 25.06%. Additionally, our subgroup analysis remained statistically significant for studies with long-term mortality. In our exploratory sub-study, the presence of AF corresponded with high risk of cardiogenic shock and fatal arrhythmia.
There have not been well-established studies conducted to examine AF prevalence in Takotsubo so far. Based on our included studies (Dib et al., 2008; El-Battrawy, Lang, Ansari, Behnes, et al., 2017; Ghadri et al, 2016; Song et al., 2010; Stiermaier, Santoro, et al., 2017) , the prevalence of AF in Takotsubo ranged from 6.40%-25.06%. Taking age into consideration, the discrepancy among these Takotsubo studies (Dib et al., 2008; El-Battrawy, Lang, Ansari, Behnes, et al., 2017; Ghadri et al, 2016; Song et al., 2010; Stiermaier, Santoro, et al., 2017) are likely from the difference of mean age among each study (Table 1) . On the other hand, from the GRACE study, McManus et al. (McManus et al., 2012) reported AF prevalence in ACS patients (Eagle et al., 2002; Investigators, 2001 ) at approximately 6.7%-8.4% and the mean age of the participants was 65.90 years old. Interestingly, two Takostubo studies (Ghadri et al, 2016; Song et al., 2010) that have similar age groups with the GRACE study reported that the prevalence ranged between 6.4%-6.9%
which is similar to the prevalence reported in ACS. However, we believe further studies are required to determine TTC prevalence given the small number of participants.
Many risk factors such as age, sex, physical trigger, lower EF and high troponin level have been proposed as prognostic determinants in TTC (Templin et al., 2015) . Recently, some studies also showed a relationship between AF and poor outcome among patients with stress cardiomyopathy (El-Battrawy, Lang, Ansari, Behnes, et al., 2017; Ghadri et al, 2016; Konstantinos et al., 2017; Pant et al., 2013; Stiermaier, Santoro, et al., 2017) . It has been known that AF is an independent adverse factor which increases morbidity and mortality (Andersson et al., 2013; Benjamin et al., 1998; Conen et al., 2011; Stewart, Hart, Hole, & McMurray, 2002) and is associated with detrimental consequences (Benjamin et al., 1998; Kannel, Abbott, Savage, & McNamara, 1982; Scardi & Mazzone, 2000; Stewart et al., 2002) , especially in susceptible groups such as patients with myocardial infarction (Chen et al., 2013; Crenshaw et al., 1997; Eldar et al., 1998; Goldberg et al., 1990) . There is a well-performed meta-analysis demonstrating increased risk of mortality in acute myocardial infarction published by Angeli et al. (2012) . This study demonstrated that risk of mortality increased approximately two times in patients with AF with ACS. Surprisingly, our results suggested a similar risk in comparison to the aforementioned study even in a different population (our study did not include CAD). This implies that pre-existing AF has significant impact on prognosis in both settings.
Tornvall, Collste, Ehrenborg, and Jarnbert-Petterson (2016) compared mortality among patients with TTC, patients with CAD and patients without CAD and argued that the mortality among patients with TTC was significantly higher compared to population without CAD. Interestingly, the study showed similar mortality rate between TTC and CAD population. Unfortunately, since our recruited participants were only patients without CAD based on Mayo clinic criteria (Madhavan & Prasad, 2010) , we were unable to examine differences in prevalence of AF and clinical significance of AF between TTC and ACS. It is worthwhile to investigate this further in the future.
The pathogenesis of AF in TTC as well as how it contributes to adverse outcomes has not been clearly elucidated. In general, AF pathogenesis typically involves electrical and structural remodeling of the left atrium (Allessie et al., 2001; Schotten, Verheule, Kirchhof, & Goette, 2011) . There are many explanations for the mechanism of AF initiation in TTC. One of them is the emergence of left atrial dysfunction in TTC patients . Previous studies have suggested that left atrial abnormality may have a role in AF pathophysiology (Dodson et al., 2014; Sanfilippo et al., 1990; Vaziri, Larson, Benjamin, & Levy, 1994) . Excessive sympathetic activity, which induces a massive release of catecholamine, is also a possible mechanism for AF development, given plausible pathophysiology of TTC (Abraham et al., 2009; Paur et al., 2012; Wittstein et al., 2005) . Inflammatory mediators could facilitate the initiation of AF as well (Gutierrez & Van Wagoner, 2015; Harada, Van Wagoner, & Nattel, 2015; Issac, Dokainish, & Lakkis, 2007) , suggested by a study showing increased levels of IL6 and IL10 among TTC patients (Santoro et al., 2016) .
Despite the fact that TTC is a reversible condition, there has been emerging evidence supporting adverse outcomes among TTC with AF (El-Battrawy, Lang, Ansari, Behnes, et al., 2017; Ghadri et al, 2016; Konstantinos et al., 2017; Pant et al., 2013; Stiermaier, Santoro, et al., 2017) . AF could lead to adverse outcomes through possible physiologies including loss of atrial contraction, rapid ventricular rate, activation of neurohormonal vasoconstrictors, and mitral regurgitation (Gertz et al., 2011) , implicating further deterioration of cardiac function. In addition, some studies suggested a noticeable association between AF and fatal arrhythmia. El-Battrawy, Lang, Ansari, Tulumen, et al. (2017) portrayed that there was a high likelihood of the occurrence of fatal arrhythmias in patient with AF. Dip et al. noticed a higher prevalence of AF among patients with life-threatening arrhythmia. Moreover, some studies reported that cardiac fibrosis and inflammation were prevalent in patients with TTC with AF (Dzeshka, Lip, Snezhitskiy, & Shantsila, 2015; Eitel et al., 2011) . Lastly, thromboembolic phenomenon especially stroke may be precipitated by AF, which leads to further consequences.
F I G U R E 2 (a) Forest plot of studies comparing all-cause mortality and long term overall mortality in patients with and without AF. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using random-effects model. A diamond data marker represents the overall adjusted odd ratio (OR) and 95% CI for the outcome of interest. (b) Forest plot of studies comparing fatal arrhythmia and cardiogenic shock in patients with and without AF. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using random-effects model. A diamond data marker represents the overall adjusted odd ratio (OR) and 95% CI for the outcome of interest. AF: atrial fibrillation
In our subgroup analyses between multivariate adjusted and unadjusted studies. We found that both multivariate adjusted and non-adjusted subgroup analyses showed substantial association between AF and risk of mortality in Takotsubo with similar OR. In meta-regression, we found that there was no significant difference among adjusted and unadjusted studies in overall random effect pooled analysis. Low heterogeneity, similar risk ratio, and non-significant meta-regression among multivariate adjusted and non-adjusted studies implies that participants' characteristics were very similar among each study due to our specific Mayo clinic Takostubo inclusion criteria (Madhavan & Prasad, 2010) . Therefore, these results confirmed accuracy and validity of our findings.
To the best of our knowledge, this is the first meta-analysis conducted to determine the impact of AF on mortality in patients with TTC. We believe that the presence of AF can be helpful for risk stratification to predict morbidity and mortality in patients with TTC.
| LI M ITATI O N
We recognize there are limitations to our meta-analysis. Studies with different methodology and population were included and might be potential sources of heterogeneity. First, since all included studies were observational in nature, the influence of residual confounders could not be completely excluded. Second, we did not further determine whether paroxysmal or persistent AF have different impacts on the outcome of interest due to insufficient data. Likewise, the presence of AF before, during or after hospitalization was not identified so that we could not analyze the relationship with mortality. Third, there were only five studies included in our study despite a relatively symmetrical funnel plot. Hence, there is a possibility of false negative result from the funnel plot. However, TTC is a very rare condition, which is still not well understood. In addition, our study did not demonstrate whether any ballooning patterns could affect the outcome with the presence of AF given lack of adequate data. Nonetheless, we used sensitivity analysis methods in the random-effects model and found no difference between the imputed risk ratio and its 95% confidence interval.
| CON CLUS ION
In summary, the presence of AF in TTC is associated with higher all-cause mortality, especially long-term mortality. According to our study, further investigations should focus on the association between type of AF or AF onset and clinical outcomes in TTC.
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F I G U R E 3 Forest plot of sub-studies (adjusted and non-adjusted subgroups) comparing all-cause mortality in patients with and without AF. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using random-effects model. A diamond data marker represents the overall adjusted odd ratio (OR) and 95% CI for the outcome of interest. AF: atrial fibrillation F I G U R E 4 Funnel plot of AF and mortality. Circles represent published studies. AF: atrial fibrillation
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